Announced Tue, 30 Jun · 12:58 IST
Trading Window closed from 1 July 2026 for Q1 results
Compliance View source PDF
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹2167.90
prior close
₹2200.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1—-0.1-0.4+1.0-1.3-3.8-1.5-4.8+1.1+14.4———
Up moveDown movePending
AI summary
Beta Drugs Limited has informed the Exchange that the trading window for its securities will be closed from 1 July 2026 until 48 hours after the declaration of unaudited financial results for Q1 ended 30 June 2026. The closure applies to all directors, officers, designated employees, their immediate relatives, and others covered under the company's Insider Trading Code, as required by SEBI regulations.
Likely market impact
Routine insider trading compliance ahead of Q1 results; insiders restricted from trading until results are declared.